Logotype for Spire Healthcare Group plc

Spire Healthcare Group (SPI) Status Update summary

Event summary combining transcript, slides, and related documents.

Logotype for Spire Healthcare Group plc

Status Update summary

8 Jul, 2026

Market opportunity and strategic rationale

  • Primary care market is large, fast-growing, and fragmented, with significant growth rates across segments such as occupational health (6%), GP services (10%), diagnostics (2%), outpatient treatments (10%), physiotherapy (4%), and talking therapies (10%).

  • The business aims to complement its hospital operations by building a scalable, standalone primary care platform, leveraging synergies and cross-referrals.

  • Integration of acquired businesses (Vita Health Group and Doctors Clinic Group) has created a national network for GP, physio, and talking therapies, targeting NHS, corporate, and B2C customers.

  • The strategy focuses on early patient engagement, cross-pollination of services, and leveraging a sophisticated data-driven model for clinic location selection.

  • Occupational health is being repositioned from advice-only to intervention-based, addressing two-thirds of workplace absences (MSK and mental health).

Financial targets and growth drivers

  • Current EBITDA is over £10 million, with a medium-term ambition to reach £40 million, supported by organic growth, new contracts, and M&A.

  • Organic growth is expected to continue at historical rates, with new clinics contributing more significantly from 2027 onwards.

  • M&A is focused on small, accretive deals, especially in occupational health and clinics, to build a national footprint and enhance service integration.

  • Double-digit EBITDA margins are targeted in the medium term, with stronger EBIT drop-through due to a capital-light model.

  • NHS contracts typically run for 5–7 years, providing revenue visibility and stability; recent renewals have extended contract durations.

Service offering and operational model

  • Four main service lines: talking therapies, physiotherapy, occupational health, and GP services, with a growing dermatology segment linked to mental health.

  • Talking therapies are 80–90% remote, supporting a capital-light, scalable model; physio and occupational health also leverage remote delivery.

  • GP services are primarily out-of-pocket B2C, with some PMI and corporate contracts; currently fee-for-service, with potential for capitation models.

  • Clinic rollout strategy uses a gravity model to optimize locations near hospitals and patient populations, with minimal CapEx per room (£30,000–£40,000).

  • Operational synergies are realized through shared back-office functions, marketing, and buying power, while maintaining separate clinical operations.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more